WP-1122

DB17192InvestigationalSmall molecule

WP-1122 is a prodrug of 2-deoxy-D-glucose (2-DG). It was granted FDA orphan designation for the treatment of glioblastoma multiforme.

Chemical structure of WP-1122
Formula / weight
C10H16O7 · 248.231 g/mol (avg)
Also known as
an acetic acid diester of 2-deoxy-D-glucose
Code names
WP 1122

Resolves to

Compound
UNII54EAA28C5Y
Structure
InChIKeyBYPTXUKSDKAPKO-OPRDCNLKSA-NSMILES[H][C@@](O)(COC(C)=O)[C@@]([H])(O)[C@@]([H])(CC=O)OC(C)=O

What you can answer from here — as of July 18, 2023

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of WP-1122, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In